<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39333139</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>27</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>A basally active cGAS-STING pathway limits SARS-CoV-2 replication in a subset of ACE2 positive airway cell models.</ArticleTitle><Pagination><StartPage>8394</StartPage><MedlinePgn>8394</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">8394</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-024-52803-7</ELocationID><Abstract><AbstractText>Host factors that define the cellular tropism of SARS-CoV-2 beyond the cognate ACE2 receptor are poorly defined. Here we report that SARS-CoV-2 replication is restricted at a post-entry step in a number of ACE2-positive airway-derived cell lines due to tonic activation of the cGAS-STING pathway mediated by mitochondrial DNA leakage and naturally occurring cGAS and STING variants. Genetic and pharmacological inhibition of the cGAS-STING and type I/III IFN pathways as well as ACE2 overexpression overcome these blocks. SARS-CoV-2 replication in STING knockout cell lines and primary airway cultures induces ISG expression but only in uninfected bystander cells, demonstrating efficient antagonism of the type I/III IFN-pathway in productively infected cells. Pharmacological inhibition of STING in primary airway cells enhances SARS-CoV-2 replication and reduces virus-induced innate immune activation. Together, our study highlights that tonic activation of the cGAS-STING and IFN pathways can impact SARS-CoV-2 cellular tropism in a manner dependent on ACE2 expression levels.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Puray-Chavez</LastName><ForeName>Maritza</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eschbach</LastName><ForeName>Jenna E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Ming</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8267-6263</Identifier><AffiliationInfo><Affiliation>Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>LaPak</LastName><ForeName>Kyle M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Qianzi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jasuja</LastName><ForeName>Ria</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Jiehong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jian</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-4050-0168</Identifier><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Zixiang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohammed</LastName><ForeName>Shawn</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qibo</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lawson</LastName><ForeName>Dana Q</ForeName><Initials>DQ</Initials><AffiliationInfo><Affiliation>Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Djokic</LastName><ForeName>Sanja</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Gaopeng</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Siyuan</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5338-260X</Identifier><AffiliationInfo><Affiliation>Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brody</LastName><ForeName>Steven L</ForeName><Initials>SL</Initials><Identifier Source="ORCID">0000-0002-0905-7527</Identifier><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Major</LastName><ForeName>Michael B</ForeName><Initials>MB</Initials><Identifier Source="ORCID">0000-0002-6753-8513</Identifier><AffiliationInfo><Affiliation>Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Otolaryngology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldfarb</LastName><ForeName>Dennis</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-1584-5423</Identifier><AffiliationInfo><Affiliation>Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Informatics, Data Science &amp; Biostatistics, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kutluay</LastName><ForeName>Sebla B</ForeName><Initials>SB</Initials><Identifier Source="ORCID">0000-0001-5549-7032</Identifier><AffiliationInfo><Affiliation>Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA. kutluay@wustl.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32CA009547-34</GrantID><Agency>U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute (NCI)</Agency><Country /></Grant><Grant><GrantID>R56 AI167285</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AI167695</GrantID><Agency>Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID)</Agency><Country /></Grant><Grant><GrantID>F31 AI167695</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 CA009547</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI167285</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.7.7.-</RegistryNumber><NameOfSubstance UI="D009713">Nucleotidyltransferases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="D000085962">Angiotensin-Converting Enzyme 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.-</RegistryNumber><NameOfSubstance UI="C578390">cGAS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C532857">STING1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="C000705307">ACE2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>9008-11-1</RegistryNumber><NameOfSubstance UI="D007372">Interferons</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>bioRxiv. 2024 Sep 06:2024.01.07.574522. doi: 10.1101/2024.01.07.574522</RefSource><PMID Version="1">38260460</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D009713" MajorTopicYN="Y">Nucleotidyltransferases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="Y">Membrane Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000085962" MajorTopicYN="Y">Angiotensin-Converting Enzyme 2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007372" MajorTopicYN="N">Interferons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007370" MajorTopicYN="N">Interferon Type I</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>9</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>9</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>23</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39333139</ArticleId><ArticleId IdType="pmc">PMC11437049</ArticleId><ArticleId IdType="doi">10.1038/s41467-024-52803-7</ArticleId><ArticleId IdType="pii">10.1038/s41467-024-52803-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chen, N. et al. Viral strategies to antagonize the host antiviral innate immunity: an indispensable research direction for emerging virus-host interactions. Emerg. Microbes Infect.13, 2341144 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11188965</ArticleId><ArticleId IdType="pubmed">38847579</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Pen, J. &amp; Rice, C. M. The antiviral state of the cell: lessons from SARS-CoV-2. Curr. Opin. Immunol.87, 102426 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11260430</ArticleId><ArticleId IdType="pubmed">38795501</ArticleId></ArticleIdList></Reference><Reference><Citation>Sievers, B. L., Cheng, M. T. K., Csiba, K., Meng, B. &amp; Gupta, R. K. SARS-CoV-2 and innate immunity: the good, the bad, and the “goldilocks. Cell Mol. Immunol.21, 171–183 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10805730</ArticleId><ArticleId IdType="pubmed">37985854</ArticleId></ArticleIdList></Reference><Reference><Citation>Walls, A. C. et al. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell181, 281–292.e286 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102599</ArticleId><ArticleId IdType="pubmed">32155444</ArticleId></ArticleIdList></Reference><Reference><Citation>Letko, M., Marzi, A. &amp; Munster, V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat. Microbiol.5, 562–569 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095430</ArticleId><ArticleId IdType="pubmed">32094589</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann, M. et al. SARS-CoV-2 Cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell181, 271–280.e278 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature579, 270–273 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095418</ArticleId><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Hikmet, F. et al. The protein expression profile of ACE2 in human tissues. Mol. Syst. Biol.16, e9610 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7383091</ArticleId><ArticleId IdType="pubmed">32715618</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguiar, J. A. et al. Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue. Eur. Respir. J.56, 10.1183/13993003.01123-2020 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7366180</ArticleId><ArticleId IdType="pubmed">32675206</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming, I. et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol.203, 631–637 (2004).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>To, K. F. &amp; Lo, A. W. Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2). J. Pathol.203, 740–743 (2004).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7167902</ArticleId><ArticleId IdType="pubmed">15221932</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, Z. et al. SARS-CoV-2 immunity in animal models. Cell Mol. Immunol.21, 119–133 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10806257</ArticleId><ArticleId IdType="pubmed">38238440</ArticleId></ArticleIdList></Reference><Reference><Citation>Behboudi, E. et al. SARS-CoV-2 mechanisms of cell tropism in various organs considering host factors. Heliyon10, e26577 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10901034</ArticleId><ArticleId IdType="pubmed">38420467</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim, S., Zhang, M. &amp; Chang, T. L. ACE2-Independent Alternative Receptors for SARS-CoV-2. Viruses14, 10.3390/v14112535 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9692829</ArticleId><ArticleId IdType="pubmed">36423144</ArticleId></ArticleIdList></Reference><Reference><Citation>Loske, J. et al. Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children. Nat. Biotechnol.40, 319–324 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34408314</ArticleId></ArticleIdList></Reference><Reference><Citation>Abt, M. C. et al. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity37, 158–170 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3679670</ArticleId><ArticleId IdType="pubmed">22705104</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown Harding, H. et al. Candida albicans extracellular vesicles trigger type I IFN signalling via cGAS and STING. Nat. Microbiol.9, 95–107 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10959075</ArticleId><ArticleId IdType="pubmed">38168615</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Domizio, J. et al. The commensal skin microbiota triggers type I IFN-dependent innate repair responses in injured skin. Nat. Immunol.21, 1034–1045 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32661363</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutierrez-Merino, J., Isla, B., Combes, T., Martinez-Estrada, F. &amp; Maluquer De Motes, C. Beneficial bacteria activate type-I interferon production via the intracellular cytosolic sensors STING and MAVS. Gut Microbes11, 771–788 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7524384</ArticleId><ArticleId IdType="pubmed">31941397</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima-Junior, D. S. et al. Endogenous retroviruses promote homeostatic and inflammatory responses to the microbiota. Cell184, 3794–3811 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8381240</ArticleId><ArticleId IdType="pubmed">34166614</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaupp, L. et al. Microbiota-induced type I interferons instruct a poised basal state of dendritic cells. Cell181, 1080–1096 e1019 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32380006</ArticleId></ArticleIdList></Reference><Reference><Citation>Wypych, T. P., Wickramasinghe, L. C. &amp; Marsland, B. J. The influence of the microbiome on respiratory health. Nat. Immunol.20, 1279–1290 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31501577</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson, R. P., Erb-Downward, J. R., Martinez, F. J. &amp; Huffnagle, G. B. The microbiome and the respiratory tract. Annu. Rev. Physiol.78, 481–504 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4751994</ArticleId><ArticleId IdType="pubmed">26527186</ArticleId></ArticleIdList></Reference><Reference><Citation>Pattaroni, C. et al. Early-life formation of the microbial and immunological environment of the human airways. Cell Host Microbe24, 857–865 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30503510</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch, S. V. &amp; Pedersen, O. The human intestinal microbiome in health and disease. N. Engl. J. Med.375, 2369–2379 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27974040</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, B. et al. Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions. Signal Transduct. Target. Ther.7, 143 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9052735</ArticleId><ArticleId IdType="pubmed">35487886</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulaiman, I. et al. Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome. Nat. Microbiol.6, 1245–1258 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8484067</ArticleId><ArticleId IdType="pubmed">34465900</ArticleId></ArticleIdList></Reference><Reference><Citation>Llorens-Rico, V. et al. Clinical practices underlie COVID-19 patient respiratory microbiome composition and its interactions with the host. Nat. Commun.12, 6243 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8556379</ArticleId><ArticleId IdType="pubmed">34716338</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo, T. et al. Alterations in fecal fungal microbiome of patients with COVID-19 during time of hospitalization until discharge. Gastroenterology159, 1302–1310 e1305 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7318920</ArticleId><ArticleId IdType="pubmed">32598884</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo, T. et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology159, 944–955.e948 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Puray-Chavez, M. et al. Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell. Cell Rep.36, 109364 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8220945</ArticleId><ArticleId IdType="pubmed">34214467</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampaio, N. G. et al. The RNA sensor MDA5 detects SARS-CoV-2 infection. Sci. Rep.11, 13638 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8249624</ArticleId><ArticleId IdType="pubmed">34211037</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebendenne, A. et al. SARS-CoV-2 triggers an MDA-5-dependent interferon response which is unable to control replication in lung epithelial cells. J. Virol.10.1128/JVI.02415-20 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8103705</ArticleId><ArticleId IdType="pubmed">33514628</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin, X. et al. MDA5 Governs the innate immune response to SARS-CoV-2 in lung epithelial cells. Cell Rep.34, 108628 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832566</ArticleId><ArticleId IdType="pubmed">33440148</ArticleId></ArticleIdList></Reference><Reference><Citation>Kouwaki, T., Nishimura, T., Wang, G. &amp; Oshiumi, H. RIG-I-Like receptor-mediated recognition of viral genomic RNA of severe acute respiratory syndrome coronavirus-2 and viral escape from the host innate immune responses. Front. Immunol.12, 700926 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8267574</ArticleId><ArticleId IdType="pubmed">34249006</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorne, L. G. et al. SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation. EMBO J.40, e107826 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8209947</ArticleId><ArticleId IdType="pubmed">34101213</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, D. M., Geng, T. T., Harrison, A. G. &amp; Wang, P. H. Differential roles of RIG-I like receptors in SARS-CoV-2 infection. Mil. Med. Res.8, 49 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8421188</ArticleId><ArticleId IdType="pubmed">34488908</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco-Melo, D. et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell181, 1036–1045 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7227586</ArticleId><ArticleId IdType="pubmed">32416070</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei, X. et al. Activation and evasion of type I interferon responses by SARS-CoV-2. Nat Commun11, 3810 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392898</ArticleId><ArticleId IdType="pubmed">32733001</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatton, C. F. et al. Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2. Nat Commun12, 7092 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8651658</ArticleId><ArticleId IdType="pubmed">34876592</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu, H. et al. Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19. Clin. Infect. Dis.71, 1400–1409 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7184390</ArticleId><ArticleId IdType="pubmed">32270184</ArticleId></ArticleIdList></Reference><Reference><Citation>Stukalov, A. et al. Multi-level proteomics reveals host-perturbation strategies of SARS-CoV-2 and SARS-CoV. Nature594, 246–252 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33845483</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjadj, J. et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science369, 718–724 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7402632</ArticleId><ArticleId IdType="pubmed">32661059</ArticleId></ArticleIdList></Reference><Reference><Citation>Galani, I. E. et al. Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison. Nat. Immunol.22, 32–40 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33277638</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard, P. et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science370, 10.1126/science.abd4585 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Goenka, A. et al. Young infants exhibit robust functional antibody responses and restrained IFN-gamma production to SARS-CoV-2. Cell Rep. Med.2, 100327 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8188298</ArticleId><ArticleId IdType="pubmed">34124701</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann, M. et al. Evidence for an ACE2-independent entry pathway that can protect from neutralization by an antibody used for COVID-19 therapy. mBio13, e0036422 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9239067</ArticleId><ArticleId IdType="pubmed">35467423</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo, K., Barrett, B. S., Mickens, K. L., Hasenkrug, K. J. &amp; Santiago, M. L. Interferon resistance of emerging SARS-CoV-2 variants. Proc. Natl. Acad. Sci. USA119, e2203760119 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9371743</ArticleId><ArticleId IdType="pubmed">35867811</ArticleId></ArticleIdList></Reference><Reference><Citation>Danziger, O., Patel, R. S., DeGrace, E. J., Rosen, M. R. &amp; Rosenberg, B. R. Inducible CRISPR activation screen for interferon-stimulated genes identifies OAS1 as a SARS-CoV-2 restriction factor. PLoS Pathog.18, e1010464 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9041830</ArticleId><ArticleId IdType="pubmed">35421191</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Sancho, L. et al. Functional landscape of SARS-CoV-2 cellular restriction. Mol. Cell81, 2656–2668 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8043580</ArticleId><ArticleId IdType="pubmed">33930332</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickenhagen, A. et al. A prenylated dsRNA sensor protects against severe COVID-19. Science374, eabj3624 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7612834</ArticleId><ArticleId IdType="pubmed">34581622</ArticleId></ArticleIdList></Reference><Reference><Citation>Haag, S. M. et al. Targeting STING with covalent small-molecule inhibitors. Nature559, 269–273 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29973723</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong, Z. et al. STING inhibitors target the cyclic dinucleotide binding pocket. Biol. Sci.118, 10.1073/pnas.2105465118 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8214703</ArticleId><ArticleId IdType="pubmed">34099558</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, M. et al. Pharmacological activation of STING blocks SARS-CoV-2 infection. Sci. Immunol.6, 10.1126/sciimmunol.abi9007 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10021026</ArticleId><ArticleId IdType="pubmed">34010142</ArticleId></ArticleIdList></Reference><Reference><Citation>Ablasser, A. et al. TREX1 deficiency triggers cell-autonomous immunity in a cGAS-dependent manner. J. Immunol.192, 5993–5997 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24813208</ArticleId></ArticleIdList></Reference><Reference><Citation>Stetson, D. B., Ko, J. S., Heidmann, T. &amp; Medzhitov, R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell134, 587–598 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2626626</ArticleId><ArticleId IdType="pubmed">18724932</ArticleId></ArticleIdList></Reference><Reference><Citation>Rongvaux, A. et al. Apoptotic caspases prevent the induction of type I interferons by mitochondrial DNA. Cell159, 1563–1577 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4272443</ArticleId><ArticleId IdType="pubmed">25525875</ArticleId></ArticleIdList></Reference><Reference><Citation>West, A. P. et al. Mitochondrial DNA stress primes the antiviral innate immune response. Nature520, 553–557 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4409480</ArticleId><ArticleId IdType="pubmed">25642965</ArticleId></ArticleIdList></Reference><Reference><Citation>Froechlich, G. et al. The common H232 STING allele shows impaired activities in DNA sensing, susceptibility to viral infection, and in monocyte cell function, while the HAQ variant possesses wild-type properties. Sci. Rep.13, 19541 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10636114</ArticleId><ArticleId IdType="pubmed">37945588</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy, R. B. et al. Polymorphisms in STING affect human innate immune responses to poxviruses. Front. Immunol.11, 567348 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7591719</ArticleId><ArticleId IdType="pubmed">33154747</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazmierski, J. et al. A baseline cellular antiviral state is maintained by cGAS and its most frequent naturally occurring variant rs610913. J. Immunol.209, 535–547 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35851540</ArticleId></ArticleIdList></Reference><Reference><Citation>Decout, A., Katz, J. D., Venkatraman, S. &amp; Ablasser, A. The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nat. Rev. Immunol.21, 548–569 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8029610</ArticleId><ArticleId IdType="pubmed">33833439</ArticleId></ArticleIdList></Reference><Reference><Citation>Contreras-Galindo, R., Dube, D., Fujinaga, K., Kaplan, M. H. &amp; Markovitz, D. M. Susceptibility of human endogenous retrovirus type K to reverse transcriptase inhibitors. J. Virol.91, 10.1128/JVI.01309-17 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5686744</ArticleId><ArticleId IdType="pubmed">28931682</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou, Y. J. et al. SARS-CoV-2 Reverse genetics reveals a variable infection gradient in the respiratory tract. Cell182, 429–446 e414 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7250779</ArticleId><ArticleId IdType="pubmed">32526206</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge, Z. &amp; Ding, S. Regulation of cGAS/STING signaling and corresponding immune escape strategies of viruses. Front. Cell Infect. Microbiol.12, 954581 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9516114</ArticleId><ArticleId IdType="pubmed">36189363</ArticleId></ArticleIdList></Reference><Reference><Citation>Hertzog, J. &amp; Rehwinkel, J. Regulation and inhibition of the DNA sensor cGAS. EMBO Rep.21, e51345 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7726805</ArticleId><ArticleId IdType="pubmed">33155371</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie, K. J. et al. cGAS surveillance of micronuclei links genome instability to innate immunity. Nature548, 461–465 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5870830</ArticleId><ArticleId IdType="pubmed">28738408</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, H., Zhou, F. &amp; Zhang, L. STING, a critical contributor to SARS-CoV-2 immunopathology. Signal Transduct. Target. Ther.7, 106 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8964922</ArticleId><ArticleId IdType="pubmed">35354788</ArticleId></ArticleIdList></Reference><Reference><Citation>Domizio, J. D. et al. The cGAS-STING pathway drives type I IFN immunopathology in COVID-19. Nature603, 145–151 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8891013</ArticleId><ArticleId IdType="pubmed">35045565</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, Z. et al. Sensing of cytoplasmic chromatin by cGAS activates innate immune response in SARS-CoV-2 infection. Signal Transduct. Target. Ther.6, 382 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8564796</ArticleId><ArticleId IdType="pubmed">34732709</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphries, F. et al. A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection. Sci. Immunol.6, 10.1126/sciimmunol.abi9002 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8158975</ArticleId><ArticleId IdType="pubmed">34010139</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, W. et al. Activation of STING signaling pathway effectively blocks human coronavirus infection. J. Virol.95, 10.1128/JVI.00490-21 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8316077</ArticleId><ArticleId IdType="pubmed">33789998</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding, S. &amp; Liang, T. J. Is SARS-CoV-2 Also an enteric Pathogen with potential fecal-oral transmission? A COVID-19 virological and clinical review. Gastroenterology159, 53–61 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7184994</ArticleId><ArticleId IdType="pubmed">32353371</ArticleId></ArticleIdList></Reference><Reference><Citation>Durairajan, S. S. K. et al. Gastrointestinal manifestations of SARS-CoV-2: Transmission, Pathogenesis, Immunomodulation, Microflora Dysbiosis, and Clinical Implications. Viruses15, 10.3390/v15061231 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10304713</ArticleId><ArticleId IdType="pubmed">37376531</ArticleId></ArticleIdList></Reference><Reference><Citation>Marino, G. et al. STING is redundant for host defense and pathology of COVID-19-like disease in mice. Life Sci. Alliance6, 10.26508/lsa.202301997 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10241217</ArticleId><ArticleId IdType="pubmed">37277149</ArticleId></ArticleIdList></Reference><Reference><Citation>Han, L. et al. SARS-CoV-2 ORF10 antagonizes STING-dependent interferon activation and autophagy. J. Med. Virol.94, 5174–5188 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9350412</ArticleId><ArticleId IdType="pubmed">35765167</ArticleId></ArticleIdList></Reference><Reference><Citation>Su, J. et al. SARS-CoV-2 ORF3a inhibits cGAS-STING-mediated autophagy flux and antiviral function. J. Med. Virol.95, e28175 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9538343</ArticleId><ArticleId IdType="pubmed">36163413</ArticleId></ArticleIdList></Reference><Reference><Citation>Rui, Y. et al. Unique and complementary suppression of cGAS-STING and RNA sensing- triggered innate immune responses by SARS-CoV-2 proteins. Signal Transduct. Target. Ther.6, 123 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7958565</ArticleId><ArticleId IdType="pubmed">33723219</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoggins, J. W. Interferon-stimulated genes: What do they all do? Annu. Rev. Virol.6, 567–584 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31283436</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazear, H. M., Schoggins, J. W. &amp; Diamond, M. S. Shared and distinct functions of type I and type III interferons. Immunity50, 907–923 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6839410</ArticleId><ArticleId IdType="pubmed">30995506</ArticleId></ArticleIdList></Reference><Reference><Citation>Sa Ribero, M., Jouvenet, N., Dreux, M. &amp; Nisole, S. Interplay between SARS-CoV-2 and the type I interferon response. PLoS Pathog.16, e1008737 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7390284</ArticleId><ArticleId IdType="pubmed">32726355</ArticleId></ArticleIdList></Reference><Reference><Citation>Setaro, A. C. &amp; Gaglia, M. M. All hands on deck: SARS-CoV-2 proteins that block early anti-viral interferon responses. Curr. Res. Virol. Sci.2, 100015 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8588586</ArticleId><ArticleId IdType="pubmed">34786565</ArticleId></ArticleIdList></Reference><Reference><Citation>Triana, S. et al. Single-cell analyses reveal SARS-CoV-2 interference with intrinsic immune response in the human gut. Mol. Syst. Biol.17, e10232 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8077299</ArticleId><ArticleId IdType="pubmed">33904651</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravindra, N. G. et al. Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes. PLoS Biol.19, e3001143 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8007021</ArticleId><ArticleId IdType="pubmed">33730024</ArticleId></ArticleIdList></Reference><Reference><Citation>Case, J. B. et al. Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2. Cell Host. Microbe28, 475–485 e475 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7332453</ArticleId><ArticleId IdType="pubmed">32735849</ArticleId></ArticleIdList></Reference><Reference><Citation>Eschbach, J. E. et al. HIV-1 capsid stability and reverse transcription are finely balanced to minimize sensing of reverse transcription products via the cGAS-STING pathway. mBio15, e0034824 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11077976</ArticleId><ArticleId IdType="pubmed">38530034</ArticleId></ArticleIdList></Reference><Reference><Citation>Horani, A. et al. Whole-exome capture and sequencing identifies HEATR2 mutation as a cause of primary ciliary dyskinesia. Am. J. Hum. Genet.91, 685–693 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3484505</ArticleId><ArticleId IdType="pubmed">23040496</ArticleId></ArticleIdList></Reference><Reference><Citation>You, Y., Richer, E. J., Huang, T. &amp; Brody, S. L. Growth and differentiation of mouse tracheal epithelial cells: selection of a proliferative population. Am. J. Physiol. Lung Cell. Mol. Physiol.283, L1315–L1321 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12388377</ArticleId></ArticleIdList></Reference><Reference><Citation>Horani, A. et al. Establishment of the early cilia preassembly protein complex during motile ciliogenesis. Proc. Natl. Acad. Sci. USA 115, E1221–E1228 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5819421</ArticleId><ArticleId IdType="pubmed">29358401</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie, X. et al. An Infectious cDNA Clone of SARS-CoV-2. Cell Host Microbe27, 841–848 e843 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7153529</ArticleId><ArticleId IdType="pubmed">32289263</ArticleId></ArticleIdList></Reference><Reference><Citation>Case, J. B., Bailey, A. L., Kim, A. S., Chen, R. E. &amp; Diamond, M. S. Growth, detection, quantification, and inactivation of SARS-CoV-2. Virology548, 39–48 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7293183</ArticleId><ArticleId IdType="pubmed">32838945</ArticleId></ArticleIdList></Reference><Reference><Citation>Shema Mugisha, C., Vuong, H. R., Puray-Chavez, M. &amp; Kutluay, S. B. A facile Q-RT-PCR assay for monitoring SARS-CoV-2 growth in cell culture. mSphere5, e00658–20 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7471006</ArticleId><ArticleId IdType="pubmed">32878932</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryant, J. D., Lei, Y., VanPortfliet, J. J., Winters, A. D. &amp; West, A. P. Assessing mitochondrial DNA release into the cytosol and subsequent activation of innate immune-related pathways in mammalian cells. Curr. Protoc.2, e372 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8986093</ArticleId><ArticleId IdType="pubmed">35175686</ArticleId></ArticleIdList></Reference><Reference><Citation>Deprez, M. et al. A single-cell atlas of the human healthy airways. Am. J. Respir. Crit. Care Med.202, 1636–1645 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32726565</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>